Smith T - Search Results

1

Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for marrow transplantation: risk factors for early regimen-related toxicity.

Przepiorka D, Dimopoulos M, Smith T, Ippoliti C, Diener K, Luna M, Champlin RE. Przepiorka D, et al. Among authors: smith t. Ann Hematol. 1994 Apr;68(4):183-8. doi: 10.1007/BF01834364. Ann Hematol. 1994. PMID: 8003559 Clinical Trial.

2

Limited value of myeloablative therapy for late multiple myeloma.

Alexanian R, Dimopoulos M, Smith T, Delasalle K, Barlogie B, Champlin R. Alexanian R, et al. Among authors: smith t. Blood. 1994 Jan 15;83(2):512-6. Blood. 1994. PMID: 7904486 Free article.

3

Adverse effects of molgramostim in marrow transplant recipients.

Ippoliti C, Przepiorka D, Smith T, Maiese S, Giralt S, Andersson BS, Deisseroth AB, Champlin RE. Ippoliti C, et al. Among authors: smith t. Clin Pharm. 1993 Jul;12(7):520-5. Clin Pharm. 1993. PMID: 8354039 No abstract available.

4

High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to neoadjuvant chemotherapy.

Ueno NT, Konoplev S, Buchholz TA, Smith T, Rondón G, Anderlini P, Giralt SA, Gajewski JL, Donato ML, Cristofanilli M, Champlin RE. Ueno NT, et al. Among authors: smith t. Bone Marrow Transplant. 2006 May;37(10):929-35. doi: 10.1038/sj.bmt.1705355. Bone Marrow Transplant. 2006. PMID: 16565737 Clinical Trial.

5

Risk of disease progression in asymptomatic multiple myeloma.

Dimopoulos MA, Moulopoulos A, Smith T, Delasalle KB, Alexanian R. Dimopoulos MA, et al. Among authors: smith t. Am J Med. 1993 Jan;94(1):57-61. doi: 10.1016/0002-9343(93)90120-e. Am J Med. 1993. PMID: 8420300

6

Impact of complete remission with intensive therapy in patients with responsive multiple myeloma.

Alexanian R, Weber D, Giralt S, Dimopoulos M, Delasalle K, Smith T, Champlin R. Alexanian R, et al. Among authors: smith t. Bone Marrow Transplant. 2001 May;27(10):1037-43. doi: 10.1038/sj.bmt.1703035. Bone Marrow Transplant. 2001. PMID: 11438818

7

Prognostic features of asymptomatic multiple myeloma.

Weber DM, Dimopoulos MA, Moulopoulos LA, Delasalle KB, Smith T, Alexanian R. Weber DM, et al. Among authors: smith t. Br J Haematol. 1997 Jun;97(4):810-4. doi: 10.1046/j.1365-2141.1997.1122939.x. Br J Haematol. 1997. PMID: 9217181 Free article.

8

Outcomes of autologous stem cell transplantation in patients with multiple myeloma who received dexamethasone-based nonmyelosuppressive induction therapy.

Anagnostopoulos A, Aleman A, Yang Y, Donato M, Weber D, Champlin R, Smith T, Alexanian R, Giralt S. Anagnostopoulos A, et al. Among authors: smith t. Bone Marrow Transplant. 2004 Mar;33(6):623-8. doi: 10.1038/sj.bmt.1704398. Bone Marrow Transplant. 2004. PMID: 14730336

9

Primary parotid lymphoma: the effect of International Prognostic Index on outcome.

Sarris AH, Papadimitrakopoulou V, Dimopoulos MA, Smith T, Pugh W, Ha CS, McLaughlin P, Callender D, Cox J, Cabanillas F. Sarris AH, et al. Among authors: smith t. Leuk Lymphoma. 1997 Jun;26(1-2):49-56. doi: 10.3109/10428199709109157. Leuk Lymphoma. 1997. PMID: 9250787

10

Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.

Dhingra K, Frye D, Newman RA, Walters R, Theriault R, Fraschini G, Smith T, Buzdar A, Hortobagyi GN. Dhingra K, et al. Among authors: smith t. Clin Cancer Res. 1995 Jul;1(7):691-7. Clin Cancer Res. 1995. PMID: 9816034 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,225 results

Search Page

Filters